News

The News section of Health Law Asia provides key updates from the healthcare landscape across China and the wider Asian region.
We share news on industry developments, institutional initiatives, international collaborations, healthcare reforms, and trends affecting the pharmaceutical, medical device, and cosmetics sectors.
A concise and reliable source to stay informed about the economic, legal, and industrial dynamics shaping Asia’s healthcare markets.

Medical Devices, Pharma, Other Countries

Singapore and Japan Strenghten Regulatory Cooperation in Health Products

See Details
Pharma, China

Bristol Myers Squibb–Hengrui Global Collaboration Agreement

See Details
Pharma, China

Further Optimizing the Review and Approval of Clinically Urgently Needed Overseas Marketed Drugs

See Details
Pharma, China

Opinions on Improving the Drug Price Formation Mechanism

See Details
Pharma, China

Guiding Opinions on the Standardized Development of Modern Pharmaceutical Logistics

See Details
Pharma, Other Countries

Singapore’s HSA Starts Accepting eCTD Packages for Regulatory Dossier Applications

See Details
Medical Devices, China

CMEF 2026 in Shanghai: A global Hub for Medical Innovation and AI-Driven Healthcare

See Details
Pharma, China

Astrazeneca establishes end to end cell therapy capabilities in Shanghai

See Details
China, Pharma, Medical Devices

China 15th Five-Year Plan and Its Implications for the Healthcare Industry

See Details
Pharma, China

Chinese Commerce Minister Meets Pharma Executives to Promote Foreign Investment

See Details
Pharma, China

Several Measures to Support the High-Quality Development of Innovative Drugs

See Details
Medical Devices, China, Pharma

Rewards for Internal Informants Reporting Issues Concerning the Quality and Safety of Medicinal Products and Medical Devices

See Details
Pharma, China

Further Enhancing Matters Related to the Issuance of the Drug Manufacturing License

See Details
Pharma, China

Import of Commercial-scale Batches of Drugs Already Marketed Abroad and Produced Prior to Approval in China

See Details
Corporate, Pharma, China

Antimonopoly Guidelines for the Pharmaceutical sector

See Details
Pharma, Corporate, China

Guidelines for Pharmaceutical Companies to Prevent Commercial Bribery Risks

See Details